You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oncolytic virus

Showing 1 - 25 of 6,405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)

Recruiting
  • Malignant Tumor
  • Oncolytic Virus SDJ001
  • Oncolytic Virus YD06-1
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 6, 2023

Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +9 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Linyi, Shandong, China
    Linyi Central Hospital
Jul 25, 2023

Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +8 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Jiangsu, China
    Xuzhou Second People's Hospital
May 8, 2023

Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?

Recruiting
  • Cervical Cancer
  • +2 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Mar 31, 2023

Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

Recruiting
  • Osteosarcoma
  • +3 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Xi'an, Shaanxi, China
    Xi'an Honghui Hospital
May 8, 2023

Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Ovarian Cancer
  • +2 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Mar 26, 2023

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Apr 13, 2023

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Cancer, Cancer of Pancreas, Sarcoma Trial (STI-1386)

Not yet recruiting
  • Cancer
  • +4 more
  • (no location specified)
Dec 15, 2022

Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)

Not yet recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection（Revottack）+PD-1
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022

T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))

Not yet recruiting
  • T-cell Lymphoma
  • +2 more
  • Oncolytic Virus Injection(RT-01)
  • (no location specified)
May 18, 2022

Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

Active, not recruiting
Has Results
  • Metastatic Non-small Cell Lung Cancer
  • Metastatic Triple-negative Breast Cancer
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Cancer Center
Dec 28, 2022

Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)

Not yet recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • CodaLytic
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(RT-01))

Recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection(RT-01)
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
May 4, 2022

CNS Tumors Trial in Beijing (OH2 injection)

Recruiting
  • Central Nervous System Tumors
  • OH2 injection
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Feb 2, 2023

Solid Tumor Trial (OH2 Injection)

Not yet recruiting
  • Solid Tumor
  • OH2 Injection
  • (no location specified)
Jul 12, 2023

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Solid Tumor Trial (BS006 Injection)

Not yet recruiting
  • Solid Tumor
  • BS006 Injection
  • (no location specified)
Jul 3, 2023

Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)

Recruiting
  • Advanced Bladder Carcinoma
  • OH2 injection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Solid Tumor, Advanced Cancer Trial in Wuxi (Oncolytic Virus Injection(RT-01))

Recruiting
  • Solid Tumor
  • Advanced Cancer
  • Oncolytic Virus Injection(RT-01)
  • Wuxi, Jiangsu, China
    Wuxi People's Hospital
Jan 19, 2022

Advanced Solid Tumor Trial in Wuxi (Oncolytic Virus Injection (RT-01))

Recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection (RT-01）
  • Wuxi, Jiangsu, China
    Wuxi People's Hospital
Jan 19, 2022